Anti‐IFN‐α/‐ω neutralizing antibodies from COVID‐19 patients correlate with downregulation of IFN response and laboratory biomarkers of disease severity
Federica Frasca(Sapienza University of Rome), Carolina Scagnolari(Istituto Pasteur), Letizia Santinelli(Sapienza University of Rome), Mirko Scordio(Sapienza University of Rome), Raphael P. Viscidi(Johns Hopkins University), Claudio Maria Mastroianni(Sapienza University of Rome), Lucia Gabriele(Istituto Superiore di Sanità), Antonio Angeloni(Policlinico Umberto I), Anna Criniti(Policlinico Umberto I), Orietta Gandini(Sapienza University of Rome), Guido Antonelli(Policlinico Umberto I), Alessandra Pierangeli(Policlinico Umberto I), Gabriella d’Ettorre(Policlinico Umberto I)
Cited by 58
Related Papers
Post-Traumatic Stress Symptoms in Healthcare Workers Dealing with the COVID-19 Pandemic: A Systematic Review
|International Journal of Environmental Research and Public Health|2021|272
Challenges in the Management of SARS-CoV2 Infection: The Role of Oral Bacteriotherapy as Complementary Therapeutic Strategy to Avoid the Progression of COVID-19
|Frontiers in Medicine|2020|218
Diet Supplementation, Probiotics, and Nutraceuticals in SARS-CoV-2 Infection: A Scoping Review
|Nutrients|2020|205
3D Microfluidic model for evaluating immunotherapy efficacy by tracking dendritic cell behaviour toward tumor cells
|Scientific Reports|2017|176
Post-traumatic Stress Disorder Among COVID-19 Survivors at 3-Month Follow-up After Hospital Discharge
|Journal of General Internal Medicine|2021|159